Alnylam Pharmaceuticals, Inc. (ALNY)
402.15
+4.90
(+1.23%)
USD |
NASDAQ |
Dec 31, 13:20
Alnylam Pharmaceuticals Price: 402.15 for Dec. 31, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 176.72 |
| Insmed, Inc. | 174.46 |
| Pfizer Inc. | 24.96 |
| Glaukos Corp. | 113.59 |
| BridgeBio Pharma, Inc. | 76.78 |
Price Related Metrics
| PE Ratio | 1672.14 |
| PS Ratio | 16.50 |
| Price to Book Value | 227.15 |
| Price to Free Cash Flow | 239.24 |
| Earnings Yield | 0.06% |
| Market Cap | 53.13B |
| Operating PE Ratio | 200.07 |
| Normalized PE Ratio | 259.43 |